Mostrar el registro sencillo del ítem
| dc.contributor.author | Wangesteen, Rosemary | |
| dc.contributor.author | Gómez-Guzman, Manuel | |
| dc.contributor.author | Banegas, Inmaculada | |
| dc.contributor.author | Rodríguez-Gómez, Isabel | |
| dc.contributor.author | Jiménez, Rosario | |
| dc.contributor.author | Duarte, Juan | |
| dc.contributor.author | García-Estañ, Joaquín | |
| dc.contributor.author | Vargas, Felix | |
| dc.date.accessioned | 2025-11-24T12:23:52Z | |
| dc.date.available | 2025-11-24T12:23:52Z | |
| dc.date.issued | 2022-06 | |
| dc.identifier.citation | Wangensteen R, Gómez-Guzmán M, Banegas I, Rodríguez-Gómez I, Jiménez R, Duarte J, et al. Vasoconstrictor and Pressor Effects of Des-Aspartate-Angiotensin I in Rat. Biomedicines. 25 de mayo de 2022;10(6):1230. | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/22133 | |
| dc.description.abstract | This study investigated the vasoactive effects of des-aspartate-angiotensin-I (DAA-I) in male Wistar rats on whole body vascular bed, isolated perfused kidneys, and aortic rings. Dose-response curves to DAA-I were compared with those to angiotensin II (Ang II). The Ang II-type-1 (AT1) receptor blocker, losartan, was used to evaluate the role of AT1 receptors in the responses to DAA-I. Studies were also conducted of the responsiveness in aortic rings after endothelium removal, nitric oxide synthase inhibition, or AT2 receptor blockade. DAA-I induced a dose-related systemic pressor response that was shifted to the right compared with Ang II. Losartan markedly attenuated the responsiveness to DAA-I. DAA-I showed a similar pattern in renal vasculature and aortic rings. In aortic rings, removal of endothelium and nitric oxide inhibition increased the sensitivity and maximal response to DAA-I and Ang II. AT2 receptor blockade did not significantly affect the responsiveness to DAA-I. According to these findings, DAA-I increases the systemic blood pressure and vascular tone in conductance and resistance vessels via AT1 receptor activation. This vasoconstrictor effect of DAA-I participates in the homeostatic control of arterial pressure, which can also contribute to the pathogenesis of hypertension. DAA-I may therefore be a potential therapeutic target in cardiovascular disease. | |
| dc.language.iso | eng | |
| dc.publisher | MDPI | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/es/ | * |
| dc.title | Vasoconstrictor and Pressor Effects of Des-Aspartate-Angiotensin I in Rat | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 35740253 | |
| dc.relation.publisherversion | https://www.mdpi.com/2227-9059/10/6/1230 | |
| dc.identifier.doi | 10.3390/biomedicines10061230 | |
| dc.journal.title | Biomedicines | |
| dc.identifier.essn | 2227-9059 |